Found: 14
Select item for more details and to access through your institution.
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-01012-6
- By:
- Publication type:
- Article
The synaptic interplay of Tau and Aβ oligomeric species in Alzheimer's disease and related tauopathies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.062586
- By:
- Publication type:
- Article
Targeted Musashi1 knockdown leads to reduce tau pathology and improves cognitive function in aged P301L mouse model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.062374
- By:
- Publication type:
- Article
Dynamic interactions and Ca<sup>2+</sup>-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seeding.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26584-2
- By:
- Publication type:
- Article
A GENETICALLY IMMORTALIZED HUMAN STEM CELL LINE: A PROMISING NEW TOOL FOR ALZHEIMER’S DISEASE THERAPY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P871, doi. 10.1016/j.jalz.2016.06.1795
- By:
- Publication type:
- Article
N-BENZYLCINNAMIDE INDUCES CHOLINERGIC NEURONAL DIFFERENTIATION FROM HUMAN AMNIOTIC FLUID MESENCHYMAL STEM CELLS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P872, doi. 10.1016/j.jalz.2016.06.1800
- By:
- Publication type:
- Article
Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55419-w
- By:
- Publication type:
- Article
A GENETICALLY IMMORTALIZED HUMAN STEM CELL LINE: A PROMISING NEW TOOL FOR ALZHEIMER'S DISEASE THERAPY.
- Published in:
- EXCLI Journal, 2015, v. 14, p. 1135, doi. 10.17179/excli2015-560
- By:
- Publication type:
- Article
Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 5, p. 1, doi. 10.1038/s41419-020-2503-3
- By:
- Publication type:
- Article
Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 754, p. 1, doi. 10.1126/scitranslmed.adj5958
- By:
- Publication type:
- Article
Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies.
- Published in:
- Molecular Neurobiology, 2023, v. 60, n. 5, p. 2691, doi. 10.1007/s12035-023-03211-3
- By:
- Publication type:
- Article
Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein.
- Published in:
- Molecular Neurobiology, 2020, v. 57, n. 6, p. 2741, doi. 10.1007/s12035-020-01913-6
- By:
- Publication type:
- Article
Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration.
- Published in:
- Aging Cell, 2019, v. 18, n. 6, p. N.PAG, doi. 10.1111/acel.13035
- By:
- Publication type:
- Article
RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18022-6
- By:
- Publication type:
- Article